[
  {
    "criterion": "Provides overly technical information about B infantis probiotic and necrotizing enterocolitis, potentially confusing the user.",
    "axis": "communication_quality",
    "point": -5
  },
  {
    "criterion": "Correctly mentions the potential benefits of B infantis probiotic in reducing necrotizing enterocolitis in very preterm babies.",
    "axis": "accuracy",
    "point": 8
  },
  {
    "criterion": "Fails to mention the potential risks associated with using B infantis probiotic in very preterm babies.",
    "axis": "completeness",
    "point": -6
  },
  {
    "criterion": "Provides a clear and concise explanation of necrotizing enterocolitis and its relationship to B infantis probiotic.",
    "axis": "communication_quality",
    "point": 7
  },
  {
    "criterion": "Does not provide any information about the dosage and administration of B infantis probiotic.",
    "axis": "completeness",
    "point": -8
  },
  {
    "criterion": "Accurately describes the current state of research on B infantis probiotic and necrotizing enterocolitis.",
    "axis": "accuracy",
    "point": 9
  },
  {
    "criterion": "Does not provide any information about the potential interactions between B infantis probiotic and other medications.",
    "axis": "completeness",
    "point": -7
  },
  {
    "criterion": "Provides a clear and concise explanation of the potential benefits and risks of using B infantis probiotic in very preterm babies.",
    "axis": "communication_quality",
    "point": 8
  }
]